Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Oncology·MeSH: Oropharyngeal Neoplasms
1 drug in development·1 company·2 clinical trials
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| Cetuximab | ADMA BIOLOGICS, INC. (ADMA) |
Frequently asked questions
How many drugs are in development for Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8?
BioSniper tracks 1 drug in development for Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 across 1 company.
How many clinical trials target Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8?
There are 2 clinical trials targeting Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 tracked by BioSniper.
Deep-dive into Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis